Tigermed's Q1 net profit drops, revenue slightly down

Hangzhou Tigermed Consulting (SZSE:300347) reported its first-quarter results for 2025, showing a net profit attributable to shareholders of CNY165.47 million, a 29.61% decrease year-over-year. The company's revenue also experienced a slight decline, falling by 5.79% to CNY1.56 billion. Net profit attributable to shareholders after deducting non-recurring gains and losses decreased sharply by 66.23% to CNY102.33 million. Operating cash flow increased 37.26% year-over-year to CNY197.93 million. Basic and diluted earnings per share both decreased by 29.63% to CNY0.19. The company noted a more than 20% increase in new contract value, exceeding CNY 2 billion. The company’s investment in digitalization continues with related expenses expected in the future.